Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,107 public trials 2,039 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Quality of Life the Danish Multiple Myeloma Patients

NCT02892383

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Sygehus Sønderjylland Aabenraa, Denmark
  • Aalborg University Hospital Aalborg, Denmark
  • Aarhus University Hospital Aarhus, Denmark
  • Rigshospitalet Copenhagen, Denmark
View Trial Details
Completed

Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]

NCT00700258

Conditions
Carcinoma, Carcinoma, Renal Cell, Advanced, Gastrointestinal Stroma Tumors, +11 more
Locations
  • Universitätsklinikum Ulm Ulm, Baden-Wurttemberg, Germany
  • Dr. med. Harald Held Neumünster, Schleswig-Holstein, Germany
  • Dr. med. Hans Wilhelm Duebbers Ahaus, Germany
  • Dr. Ludwig Fischer von Weikersthal Amberg, Germany
View all 77 locations
View Trial Details
Completed

Mechanisms of Severe Acute Influenza Consortium (MOSAIC)

NCT00965354

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +15 more
Locations
  • Alder Hey Children's Foundation NHS Trust Liverpool, United Kingdom
  • Royal Liverpool University Hospital Liverpool, United Kingdom
  • Liverpool Women's NHS Foundation Trust Liverpool, United Kingdom
  • Aintree Hospitals NHS Trust Liverpool, United Kingdom
View Trial Details
Completed

Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan

NCT04551989

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Gunma, Japan
  • GSK Investigational Site Hyōgo, Japan
  • GSK Investigational Site Hyōgo, Japan
View all 34 locations
View Trial Details
Completed

A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

NCT02616640

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Local Institution - 102 Baltimore, Maryland, United States
  • Local Institution - 114 Boston, Massachusetts, United States
  • Local Institution - 108 Boston, Massachusetts, United States
  • Local Institution - 115 Boston, Massachusetts, United States
View all 22 locations
View Trial Details

Related conditions